文献速递产科母胎医学

重大产科综合征与胎盘

The great obstetrical syndromes and the placenta.
PubMed 文献 · BJOG · 2023-08-02

综述指出子痫前期、早产、胎盘早剥、胎儿生长受限和死产虽临床表现不同,但胎盘及其发育异常是这些疾病的共同根源,统称「重大产科综合征」。深胎盘形成失败(10-18周经第二波绒毛外滋养细胞侵袭完成从组织营养性胎盘向血绒膜胎盘转变)是关键发病机制,母体炎症和血栓形成参与其中。早期开始低剂量阿司匹林通过抑制COX-1(血栓)和COX-2(炎症)可预防子痫前期及重大产科综合征的所有组分。

要点

  • 重大产科综合征包括子痫前期、早产、胎盘早剥、胎儿生长受限和死产,胎盘发育异常是共同根源。
  • 深胎盘形成失败(10-18周第二波绒毛外滋养细胞侵袭不足)是重大产科综合征的关键发病机制。
  • 早期启动低剂量阿司匹林通过抑制COX-1和COX-2预防子痫前期及重大产科综合征所有组分。

核心结论

  • 胎盘及其发育异常是重大产科综合征的共同根源,深胎盘形成失败是关键发病机制。
  • 早期启动低剂量阿司匹林可预防子痫前期及重大产科综合征的所有组分。
  • 低剂量阿司匹林在妊娠期最大有效的最佳剂量仍是待进一步研究的问题。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • 深胎盘形成失败指10-18周经第二波绒毛外滋养细胞侵袭完成从组织营养性胎盘向血绒膜胎盘的转变失败。
  • 母体炎症和血栓形成与胎盘深胎盘形成失败明确相关。
  • 低剂量阿司匹林影响COX-1受体(血栓)和COX-2受体(炎症)。
  • 已识别其他可能预防子痫前期的候选药物,其中羟氯喹、二甲双胍和普伐他汀三种已知可减轻炎症。

关键数值与推荐

  • 早期启动低剂量阿司匹林可预防子痫前期及重大产科综合征的所有组分。
  • 低剂量阿司匹林在妊娠期最大有效的最佳剂量仍是待进一步研究的问题。

临床怎么用

  • 早期启动低剂量阿司匹林以预防子痫前期及重大产科综合征的所有组分。
  • 低剂量阿司匹林的最佳剂量尚未确定,原文未据此给出具体推荐。

局限性

  • 低剂量阿司匹林在妊娠期最大有效的最佳剂量仍是待进一步研究的问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although historically pre-eclampsia, preterm birth, abruption, fetal growth restriction and stillbirth have been viewed as clinically distinct entities, a growing body of literature has demonstrated that the placenta and its development is the root cause of many cases of these conditions. This has led to the term 'the great obstetrical syndromes' being coined to reflect this common origin. Although these conditions mostly manifest in the second half of pregnancy, a failure to complete deep placentation (the transition from histiotrophic placentation to haemochorial placenta at 10-18 weeks of gestation via a second wave of extravillous trophoblast invasion), is understood to be key to the pathogenesis of the great obstetrical syndromes. While the reasons that the placenta fails to achieve deep placentation remain active areas of investigation, maternal inflammation and thrombosis have been clearly implicated. From a clinical standpoint these mechanisms provide a biological explanation of how low-dose aspirin, which affects the COX-1 receptor (thrombosis) and the COX-2 receptor (inflammation), prevents not just pre-eclampsia but all the components of the great obstetrical syndromes if initiated early in pregnancy. The optimal dose of low-dose aspirin that is maximally effective in pregnancy remains a question open for further research. Additionally, other candidate medications have been identified that may also prevent pre-eclampsia, and further study of them may offer therapeutic options beyond low-dose aspirin. Interestingly, three of the eight identified compounds (hydroxychloroquine, metformin and pravastatin) are known to decrease inflammation.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Hoffman MK. The great obstetrical syndromes and the placenta. BJOG. 2023. PMID: 37530495. doi:10.1111/1471-0528.17613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。